← Open Payments lookup

ZACHARY ROBINSON: Open Payments

NPI 1942934179 · PEARL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,137 in 51 payments from 11 companies in 2025. Trend: 2023 $1,023 · 2024 $1,468 · 2025 $1,137

Food & beverage: $1,137
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$301
Alkermes, Inc.10$209
Neurocrine BioSciences, Inc.6$128
Janssen Pharmaceuticals, Inc5$126
Vanda Pharmaceuticals Inc.2$101
Teva Pharmaceuticals USA, Inc.4$80
Otsuka America Pharmaceutical, Inc.3$55
ABBVIE INC.2$49
Lundbeck LLC2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: COBENFY, ARISTADA, INGREZZA, INVEGA SUSTENNA, FANAPT, LYBALVI, REXULTI, UZEDY.

Industry payments across MS — which companies pay providers there.